Lowenstein Sandler PC

	Firm Represents LifeCell in $1.7 Billion Sale to Kinetic Concepts Lowenstein is representing long time client LifeCell Corporation in connection with its $1.7 billion sale to Kinetic Concepts, Inc. The all cash deal, structured as a front end tender offer with a back end merger, is expected to close in the second or third quarter of 2008. The Lowenstein team advising LifeCell on the transaction consisted of Steve Fuerst, Alan Wovsaniker, Steve Skolnick, Ethan Skerry, Andrea Brown and Michael Lestino, with support from David Wissert and Jeri Abrams. Lowenstein is representing long time client LifeCell Corporation in connection with its $1.7 billion sale to Kinetic Concepts, Inc. The all cash deal, structured as a front end tender offer with a back end merger, is expected to close in the second or third quarter of 2008. The Lowenstein team advising LifeCell on the transaction consisted of Steve Fuerst, Alan Wovsaniker, Steve Skolnick, Ethan Skerry, Andrea Brown and Michael Lestino, with support from David Wissert and Jeri Abrams. FIRM REPRESENTS CELLDEX IN $129 MILLION MERGER WITH AVANT Lowenstein Sandler advised Celldex Therapeutics, Inc. a biopharmaceutical immunotherapeutics company, in connection with its stock-for-stock merger with AVANT Immunotherapeutics, Inc. The merger closed in March 2008 and produced the combined company AVANT Immunotherapeutics, Inc., which has a market capitalization of approximately $129 million and is listed on NASDAQ. The Lowenstein team advising Celldex was led by Anthony Pergola, Ethan Skerry and Niamh O'Leary-Liu. Lowenstein Sandler advised Celldex Therapeutics, Inc. a biopharmaceutical immunotherapeutics company, in connection with its stock-for-stock merger with AVANT Immunotherapeutics, Inc. The merger closed in March 2008 and produced the combined company AVANT Immunotherapeutics, Inc., which has a market capitalization of approximately $129 million and is listed on NASDAQ. The Lowenstein team advising Celldex was led by Anthony Pergola, Ethan Skerry and Niamh O'Leary-Liu. FIRM REPRESENTS CERBERUS IN ITS $1.1 BILLION ACQUISITION OF TOWER AUTOMOTIVE Lowenstein Sandler serves as lead counsel to Cerberus Capital Management, L.P. in its $1.1 billion acquisition through a chapter 11 bankruptcy proceeding of Tower Automotive Inc., a global manufacturer of vehicle components. The team was led by Robert Minion, Jeffrey Shapiro, Alan Wovsaniker, Paul Kizel, Jack Sherwood, Lowell Citron, Richard Bernstein and Timothy Wheeler. Lowenstein Sandler has represented Cerberus in a wide variety of transactions and matters since 1994. Lowenstein Sandler serves as lead counsel to Cerberus Capital Management, L.P. in its $1.1 billion acquisition through a chapter 11 bankruptcy proceeding of Tower Automotive Inc., a global manufacturer of vehicle components. The team was led by Robert Minion, Jeffrey Shapiro, Alan Wovsaniker, Paul Kizel, Jack Sherwood, Lowell Citron, Richard Bernstein and Timothy Wheeler. Lowenstein Sandler has represented Cerberus in a wide variety of transactions and matters since 1994. FIRM REPRESENTS UNDERWRITERS IN $465 MILLION IPO BY UNITED REFINING ENERGY CORP. Lowenstein Sandler recently represented Deutsche Bank Securities Inc. & Maxim Group LLC as representatives of the underwriters for the $465M initial public offering of United Refining Energy Corp. The Lowenstein team was led by Steven Skolnick and included Tom Levato, Brooke Gillar and Andrea Brown. Lowenstein Sandler recently represented Deutsche Bank Securities Inc. & Maxim Group LLC as representatives of the underwriters for the $465M initial public offering of United Refining Energy Corp. The Lowenstein team was led by Steven Skolnick and included Tom Levato, Brooke Gillar and Andrea Brown. Firm Achieves Reversal of Judgment Against Ford Lowenstein won reversal of a significant judgment against client Ford Motor Company in a case with important consequences for truck chassis cab manufacturers. The Appellate Division of the NJ Superior Court agreed that it was "neither feasible nor practical" for Ford to assume legal responsibility for providing a safety device when a later manufacturer would determine the vehicle's final configuration. Douglas Eakeley, together with Alan Modlinger and Natalie Kraner, argued the appeal. Lowenstein won reversal of a significant judgment against client Ford Motor Company in a case with important consequences for truck chassis cab manufacturers. The Appellate Division of the NJ Superior Court agreed that it was "neither feasible nor practical" for Ford to assume legal responsibility for providing a safety device when a later manufacturer would determine the vehicle's final configuration. Douglas Eakeley, together with Alan Modlinger and Natalie Kraner, argued the appeal.

Lowenstein Pro Bono Practice Ranks First in New Jersey

For the third consecutive year, Lowenstein Sandler has earned an A+ rating from the New Jersey Law Journal for its pro bono work in New Jersey. The firm ranks first in the state for the number of pro bono hours per attorney.

Proposed Amendments to Regulation S-P

The Investment Management Group discusses proposed amendments to regulation S-P (the SEC's privacy regulation for consumer financial information) and how these changes might impact covered institutions.

Lowenstein to Participate in PharmaBiotech IP Summit

On May 29, 2008, Robert J. Paradiso will participate in a panel discussion entitled "Patent Reform, Resolutions & Additional Rulings - Interpretations, Impacts and Strategies for the Challenge Ahead" at the PharmaBiotech IP Summit.

Attorney Advertising